MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,290,181 | +37.4% | 494,764 | 0.0% | 0.03% | +40.0% |
| Q2 2022 | $2,394,658 | -52.1% | 494,764 | -7.5% | 0.02% | -35.5% |
| Q1 2022 | $5,000,043 | -4.3% | 534,764 | +21.6% | 0.03% | 0.0% |
| Q4 2021 | $5,224,396 | +4.4% | 439,764 | 0.0% | 0.03% | -13.9% |
| Q3 2021 | $5,004,514 | +1723.6% | 439,764 | +2774.8% | 0.04% | +1700.0% |
| Q2 2021 | $274,428 | -95.8% | 15,297 | -97.0% | 0.00% | -97.2% |
| Q3 2020 | $6,533,000 | – | 508,423 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |